Toshinori Higashikata

Circulating Matrix Metalloproteinases and Their Inhibitors in Premature Coronary Atherosclerosis

Yoshihiro Noji, Kouji Kajinami, Masa‐aki Kawashiri et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2001 · 151 citations

Efficacy and Safety of Alirocumab in Japanese Patients With Heterozygous Familial Hypercholesterolemia or at High Cardiovascular Risk With Hypercholesterolemia Not Adequately Controlled With Statins　– ODYSSEY JAPAN Randomized Controlled Trial –

Tamio Teramoto, Masahiko Kobayashi, Hiromi Tasaki et al. · Circulation Journal · 2016 · 127 citations · Full text

Reduction of Serum Ubiquinol-10 and Ubiquinone-10 Levels by Atorvastatin in Hypercholesterolemic Patients

Hiroshi Mabuchi, Toshinori Higashikata, Masa‐aki Kawashiri et al. · Journal of Atherosclerosis and Thrombosis · 2005 · 115 citations · Full text

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 112 citations · Full text

Cholesteryl ester transfer protein inhibitor (JTT-705) and the development of atherosclerosis in rabbits with severe hypercholesterolaemia

Zhiping Huang, Akihiro Inazu, Atsushi Nohara et al. · Clinical Science · 2002 · 112 citations · Full text